Birgitt Schüle

7.9k total citations · 2 hit papers
59 papers, 4.2k citations indexed

About

Birgitt Schüle is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Birgitt Schüle has authored 59 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 27 papers in Molecular Biology and 24 papers in Cellular and Molecular Neuroscience. Recurrent topics in Birgitt Schüle's work include Parkinson's Disease Mechanisms and Treatments (33 papers), Neurological disorders and treatments (15 papers) and Pluripotent Stem Cells Research (13 papers). Birgitt Schüle is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (33 papers), Neurological disorders and treatments (15 papers) and Pluripotent Stem Cells Research (13 papers). Birgitt Schüle collaborates with scholars based in United States, Germany and Mexico. Birgitt Schüle's co-authors include J. William Langston, Theo D. Palmer, Renee A. Reijo Pera, Blake Byers, Branden Cord, Uta Francke, Amy Manning-Bog, Aleksandr Shcheglovitov, Ricardo E. Dolmetsch and Kehkooi Kee and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and PLoS ONE.

In The Last Decade

Birgitt Schüle

57 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress

2011 571 citations Ha Nguyen, Blake Byers et al. Cell stem cell profile →
Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson’s Disease

2016 361 citations Atossa Shaltouki, Ashley E. Gonzalez et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Birgitt Schüle United States	31	2.2k	2.0k	1.3k	781	550	59	4.2k
Lamya S. Shihabuddin United States	40	3.1k 1.4×	1.8k 0.9×	1.8k 1.3×	1.9k 2.4×	712 1.3×	76	6.2k
Clotilde Lagier‐Tourenne United States	29	4.1k 1.8×	3.4k 1.7×	1.2k 0.9×	609 0.8×	419 0.8×	41	6.5k
S. Pablo Sardi United States	33	2.0k 0.9×	2.0k 1.0×	908 0.7×	2.0k 2.6×	248 0.5×	69	5.0k
Katja Lohmann Germany	36	1.2k 0.5×	2.2k 1.1×	1.3k 1.0×	420 0.5×	619 1.1×	145	3.7k
Natalia Ninkina United Kingdom	38	1.8k 0.8×	2.1k 1.0×	1.4k 1.1×	988 1.3×	191 0.3×	103	4.3k
Sami J. Barmada United States	33	2.7k 1.2×	2.2k 1.1×	669 0.5×	583 0.7×	232 0.4×	80	4.2k
Willeke van Roon‐Mom Netherlands	39	2.8k 1.3×	778 0.4×	2.1k 1.5×	438 0.6×	359 0.7×	109	4.6k
Sandra Almeida United States	29	2.1k 0.9×	2.0k 1.0×	854 0.6×	697 0.9×	180 0.3×	45	3.6k
Laurent Roybon Sweden	30	1.8k 0.8×	1.1k 0.5×	1.2k 0.9×	638 0.8×	224 0.4×	64	3.6k
Wado Akamatsu Japan	35	2.6k 1.2×	481 0.2×	929 0.7×	484 0.6×	452 0.8×	89	3.7k

Countries citing papers authored by Birgitt Schüle

Since Specialization

Citations

This map shows the geographic impact of Birgitt Schüle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgitt Schüle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgitt Schüle more than expected).

Fields of papers citing papers by Birgitt Schüle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgitt Schüle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgitt Schüle. The network helps show where Birgitt Schüle may publish in the future.

Co-authorship network of co-authors of Birgitt Schüle

This figure shows the co-authorship network connecting the top 25 collaborators of Birgitt Schüle. A scholar is included among the top collaborators of Birgitt Schüle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgitt Schüle. Birgitt Schüle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kirik, Deniz, et al.. (2023). Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s disease. Scientific Reports. 13(1). 17796–17796. 8 indexed citations

Schüle, Birgitt, et al.. (2022). Gene Expression Analysis in Stem Cell-derived Cortical Neuronal Cultures Using Multi-well SYBR Green Quantitative PCR Arrays. BIO-PROTOCOL. 12(14).

Marras, Connie, Naomi P. Visanji, David Cornforth, et al.. (2019). Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson’s disease. Clinical Autonomic Research. 29(6). 603–614. 11 indexed citations

Dhekne, Herschel S., Izumi Yanatori, Francesca Tonelli, et al.. (2018). A pathway for Parkinson’s Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain. eLife. 7. 161 indexed citations

Lee, Kelsey, et al.. (2017). Derivation of Leptomeninges Explant Cultures from Postmortem Human Brain Donors. Journal of Visualized Experiments. 4 indexed citations

Shaltouki, Atossa, Ashley E. Gonzalez, Alexandre Bettencourt da Cruz, et al.. (2016). Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson’s Disease. Cell stem cell. 19(6). 709–724. 361 indexed citations breakdown →

Zhu, Fangfang, Simon Hippenmeyer, Bosiljka Tasic, et al.. (2013). DICE, an efficient system for iterative genomic editing in human pluripotent stem cells. Nucleic Acids Research. 42(5). e34–e34. 87 indexed citations

Sanders, Laurie H., Josée Laganière, Oliver Cooper, et al.. (2013). LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction. Neurobiology of Disease. 62. 381–386. 216 indexed citations

Kim, Seongseop, et al.. (2013). Skin Punch Biopsy Explant Culture for Derivation of Primary Human Fibroblasts. Journal of Visualized Experiments. e3779–e3779. 112 indexed citations

10.

Gardai, Shyra J., Birgitt Schüle, M. A. Babcock, et al.. (2013). Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease. PLoS ONE. 8(8). e71634–e71634. 83 indexed citations

11.

Mak, Sally K., et al.. (2011). Mitochondrial Dysfunction in Skin Fibroblasts from a Parkinson's Disease Patient with an alpha-Synuclein Triplication. Journal of Parkinson s Disease. 1(2). 175–183. 25 indexed citations

12.

Nguyen, Ha, Blake Byers, Branden Cord, et al.. (2011). LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress. Cell stem cell. 8(3). 267–280. 571 indexed citations breakdown →

13.

Manning-Bog, Amy, Birgitt Schüle, & J. William Langston. (2009). Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism. NeuroToxicology. 30(6). 1127–1132. 150 indexed citations

14.

Schüle, Birgitt, Renee A. Reijo Pera, & J. William Langston. (2009). Can cellular models revolutionize drug discovery in Parkinson's disease?. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1792(11). 1043–1051. 55 indexed citations

15.

Schüle, Birgitt, et al.. (2008). Severe congenital encephalopathy caused by MECP2 null mutations in males: central hypoxia and reduced neuronal dendritic structure. Clinical Genetics. 74(2). 116–126. 73 indexed citations

16.

Raymond, Deborah, Rachel Saunders‐Pullman, Patrícia de Carvalho Aguiar, et al.. (2008). Phenotypic spectrum and sex effects in eleven myoclonus‐dystonia families with ε‐sarcoglycan mutations. Movement Disorders. 23(4). 588–592. 35 indexed citations

17.

Schüle, Birgitt, et al.. (2007). DLX5 and DLX6 Expression Is Biallelic and Not Modulated by MeCP2 Deficiency. The American Journal of Human Genetics. 81(3). 492–506. 47 indexed citations

18.

Tetrud, James W., et al.. (2006). Novel features in a patient homozygous for the L347P mutation in the PINK1 gene. Parkinsonism & Related Disorders. 13(6). 359–361. 11 indexed citations

19.

Kostić, Vladimir, Marina Svetel, Kemal Kabakci, et al.. (2006). Intrafamilial phenotypic and genetic heterogeneity of dystonia. Journal of the Neurological Sciences. 250(1-2). 92–96. 9 indexed citations

20.

Klein, Christine, Ana Djarmati, Katja Hedrich, et al.. (2005). PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism. European Journal of Human Genetics. 13(9). 1086–1093. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact